Pesquisar
Cytosorbents Corp
CTSOAdicionar à lista de desejos
0.361USD
+0.011+3.08%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
22.66MValor de mercado
PerdaP/L TTM
Mais detalhes de Cytosorbents Corp Empresa
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.
Informações de Cytosorbents Corp
Código da empresaCTSO
Nome da EmpresaCytosorbents Corp
Data de listagemJun 17, 2005
CEOChan (Phillip P)
Número de funcionários149
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 17
Endereço305 College Road East
CidadePRINCETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08540
Telefone19733298885
Sitehttps://cytosorbents.com/
Código da empresaCTSO
Data de listagemJun 17, 2005
CEOChan (Phillip P)
Executivos da empresa Cytosorbents Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Phillip P. Chan, M.D., Ph.D.
Dr. Phillip P. Chan, M.D., Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.37M
+24.62%
Mr. Vincent J. Capponi
Mr. Vincent J. Capponi
President, Chief Operating Officer
President, Chief Operating Officer
429.67K
+15.09%
Mr. Peter J. (Pete) Mariani, CPA
Mr. Peter J. (Pete) Mariani, CPA
Chief Financial Officer
Chief Financial Officer
216.61K
+46.17%
Mr. Alan D. Sobel, CPA
Mr. Alan D. Sobel, CPA
Independent Director
Independent Director
78.46K
--
Ms. Jiny Kim
Ms. Jiny Kim
Independent Director
Independent Director
8.52K
--
Dr. Edward R. Jones, M.D.
Dr. Edward R. Jones, M.D.
Independent Director
Independent Director
--
--
Mr. Michael G. Bator
Mr. Michael G. Bator
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Efthymios N. Deliargyris, M.D.
Dr. Efthymios N. Deliargyris, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Phillip P. Chan, M.D., Ph.D.
Dr. Phillip P. Chan, M.D., Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.37M
+24.62%
Mr. Vincent J. Capponi
Mr. Vincent J. Capponi
President, Chief Operating Officer
President, Chief Operating Officer
429.67K
+15.09%
Mr. Peter J. (Pete) Mariani, CPA
Mr. Peter J. (Pete) Mariani, CPA
Chief Financial Officer
Chief Financial Officer
216.61K
+46.17%
Mr. Alan D. Sobel, CPA
Mr. Alan D. Sobel, CPA
Independent Director
Independent Director
78.46K
--
Ms. Jiny Kim
Ms. Jiny Kim
Independent Director
Independent Director
8.52K
--
Dr. Edward R. Jones, M.D.
Dr. Edward R. Jones, M.D.
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Cytosorbents Corp?
Os cinco principais acionistas de Cytosorbents Corp são: Dr. Phillip P. Chan, M.D., Ph.D.
Quantas instituições possuem ações da Cytosorbents Corp (CTSO)?
Em 2026Q1, 97 instituições possuíam ações da Cytosorbents Corp, com valor de mercado aproximado de 16.20M, representando 25.84% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1030604.00.